Eurazeo


Q1-24 : A sluggish start to the year

16/05/24 -"Although had been expecting private equity activity to pick up in 2024, Eurazeo’s Q1-24 performance failed to live up to expectations. While AUM were up by 8% yoy and held steady qoq, ..."

Pages
61
Language
English
Published on
16/05/24
You may also be interested by these reports :
02/09/26
Since Exor’s reclassification as an “Investment Entity” under IFRS 10, dividend income has become the primary driver of reported earnings, as ...

01/09/26
PG H1 earnings were disappointing. They shouldn’t be, as they merely reflect a drop in realisations. The strategy and steering remain convincing. The ...

28/08/26
Ackermans & van Haaren delivered a very strong H1-26, with net profit up 24% yoy to c. €340m and core business contribution up 13%. Management ...

28/08/26
As would be expected the Swiss way of managing money cannot be in abstraction from world markets. The ytd performance in Euro of the 5 Swiss stocks ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO